Literature DB >> 29298883

Cell-to-Cell Measles Virus Spread between Human Neurons Is Dependent on Hemagglutinin and Hyperfusogenic Fusion Protein.

Yuma Sato1, Shumpei Watanabe1,2, Yoshinari Fukuda1, Takao Hashiguchi1, Yusuke Yanagi3, Shinji Ohno3,4.   

Abstract

Measles virus (MV) usually causes acute infection but in rare cases persists in the brain, resulting in subacute sclerosing panencephalitis (SSPE). Since human neurons, an important target affected in the disease, do not express the known MV receptors (signaling lymphocyte activation molecule [SLAM] and nectin 4), how MV infects neurons and spreads between them is unknown. Recent studies have shown that many virus strains isolated from SSPE patients possess substitutions in the extracellular domain of the fusion (F) protein which confer enhanced fusion activity. Hyperfusogenic viruses with such mutations, unlike the wild-type MV, can induce cell-cell fusion even in SLAM- and nectin 4-negative cells and spread efficiently in human primary neurons and the brains of animal models. We show here that a hyperfusogenic mutant MV, IC323-F(T461I)-EGFP (IC323 with a fusion-enhancing T461I substitution in the F protein and expressing enhanced green fluorescent protein), but not the wild-type MV, spreads in differentiated NT2 cells, a widely used human neuron model. Confocal time-lapse imaging revealed the cell-to-cell spread of IC323-F(T461I)-EGFP between NT2 neurons without syncytium formation. The production of virus particles was strongly suppressed in NT2 neurons, also supporting cell-to-cell viral transmission. The spread of IC323-F(T461I)-EGFP was inhibited by a fusion inhibitor peptide as well as by some but not all of the anti-hemagglutinin antibodies which neutralize SLAM- or nectin-4-dependent MV infection, suggesting the presence of a distinct neuronal receptor. Our results indicate that MV spreads in a cell-to-cell manner between human neurons without causing syncytium formation and that the spread is dependent on the hyperfusogenic F protein, the hemagglutinin, and the putative neuronal receptor for MV.IMPORTANCE Measles virus (MV), in rare cases, persists in the human central nervous system (CNS) and causes subacute sclerosing panencephalitis (SSPE) several years after acute infection. This neurological complication is almost always fatal, and there is currently no effective treatment for it. Mechanisms by which MV invades the CNS and causes the disease remain to be elucidated. We have previously shown that fusion-enhancing substitutions in the fusion protein of MVs isolated from SSPE patients contribute to MV spread in neurons. In this study, we demonstrate that MV bearing the hyperfusogenic mutant fusion protein spreads between human neurons in a cell-to-cell manner. Spread of the virus was inhibited by a fusion inhibitor peptide and antibodies against the MV hemagglutinin, indicating that both the hemagglutinin and hyperfusogenic fusion protein play important roles in MV spread between human neurons. The findings help us better understand the disease process of SSPE.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  SSPE; central nervous system infections; measles; persistent infection; receptors; virus entry

Mesh:

Substances:

Year:  2018        PMID: 29298883      PMCID: PMC5827375          DOI: 10.1128/JVI.02166-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently.

Authors:  Maino Tahara; Makoto Takeda; Fumio Seki; Takao Hashiguchi; Yusuke Yanagi
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

2.  Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology.

Authors:  Shumpei Watanabe; Shinji Ohno; Yuta Shirogane; Satoshi O Suzuki; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

3.  Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.

Authors:  William J Bellini; Jennifer S Rota; Luis E Lowe; Russell S Katz; Paul R Dyken; Sherif R Zaki; Wun-Ju Shieh; Paul A Rota
Journal:  J Infect Dis       Date:  2005-10-12       Impact factor: 5.226

4.  Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters.

Authors:  Shumpei Watanabe; Yuta Shirogane; Satoshi O Suzuki; Satoshi Ikegame; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

5.  Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis.

Authors:  Masashi Shingai; Minoru Ayata; Hiroshi Ishida; Isamu Matsunaga; Yuko Katayama; Tsukasa Seya; Hironobu Tatsuo; Yusuke Yanagi; Hisashi Ogura
Journal:  J Gen Virol       Date:  2003-08       Impact factor: 3.891

6.  Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro.

Authors:  P W Andrews
Journal:  Dev Biol       Date:  1984-06       Impact factor: 3.582

7.  The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope.

Authors:  Maino Tahara; Shinji Ohno; Kouji Sakai; Yuri Ito; Hideo Fukuhara; Katsuhiro Komase; Melinda A Brindley; Paul A Rota; Richard K Plemper; Katsumi Maenaka; Makoto Takeda
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

8.  SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein.

Authors:  Koji Hashimoto; Nobuyuki Ono; Hironobu Tatsuo; Hiroko Minagawa; Makoto Takeda; Kaoru Takeuchi; Yusuke Yanagi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Nerve cell fusion in a case of subacute sclerosing panencephalitis.

Authors:  M M Paula-Barbosa; C Cruz
Journal:  Ann Neurol       Date:  1981-04       Impact factor: 10.422

10.  Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus.

Authors:  Ryan S Noyce; Daniel G Bondre; Michael N Ha; Liang-Tzung Lin; Gary Sisson; Ming-Sound Tsao; Christopher D Richardson
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

View more
  15 in total

1.  Weak cis and trans Interactions of the Hemagglutinin with Receptors Trigger Fusion Proteins of Neuropathogenic Measles Virus Isolates.

Authors:  Yuta Shirogane; Takao Hashiguchi; Yusuke Yanagi
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

2.  Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route.

Authors:  Cyrille Mathieu; Marion Ferren; Eric Jurgens; Claire Dumont; Ksenia Rybkina; Olivia Harder; Debora Stelitano; Silvia Madeddu; Giuseppina Sanna; Dayna Schwartz; Sudipta Biswas; Diana Hardie; Takao Hashiguchi; Anne Moscona; Branka Horvat; Stefan Niewiesk; Matteo Porotto
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

3.  Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination.

Authors:  Laura Papetti; Maria Elisa Amodeo; Letizia Sabatini; Melissa Baggieri; Alessandro Capuano; Federica Graziola; Antonella Marchi; Paola Bucci; Emilio D'Ugo; Maedeh Kojouri; Silvia Gioacchini; Carlo Efisio Marras; Carlotta Ginevra Nucci; Fabiana Ursitti; Giorgia Sforza; Michela Ada Noris Ferilli; Gabriele Monte; Romina Moavero; Federico Vigevano; Massimiliano Valeriani; Fabio Magurano
Journal:  Viruses       Date:  2022-03-31       Impact factor: 5.818

4.  Short-Stalk Isoforms of CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Interacting with the Viral Hemagglutinin.

Authors:  Ryuichi Takemoto; Tateki Suzuki; Takao Hashiguchi; Yusuke Yanagi; Yuta Shirogane
Journal:  J Virol       Date:  2021-11-17       Impact factor: 6.549

5.  Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain.

Authors:  Fabrizio Angius; Heidi Smuts; Ksenia Rybkina; Debora Stelitano; Brian Eley; Jo Wilmshurst; Marion Ferren; Alexandre Lalande; Cyrille Mathieu; Anne Moscona; Branka Horvat; Takao Hashiguchi; Matteo Porotto; Diana Hardie
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

6.  Fitness selection of hyperfusogenic measles virus F proteins associated with neuropathogenic phenotypes.

Authors:  Satoshi Ikegame; Takao Hashiguchi; Chuan-Tien Hung; Kristina Dobrindt; Kristen J Brennand; Makoto Takeda; Benhur Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

7.  CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Acting in cis.

Authors:  Yuta Shirogane; Ryuichi Takemoto; Tateki Suzuki; Tomonori Kameda; Kinichi Nakashima; Takao Hashiguchi; Yusuke Yanagi
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

8.  Measles inclusion body encephalitis.

Authors:  Iban Aldecoa; Iván Archilla; Laura Herrero; Felipe Garcia; Berta Torres; Carles Gaig; Sara Fernández; María Ángeles Marcos; Ellen Gelpi
Journal:  Clin Neuropathol       Date:  2020 Jul/Aug       Impact factor: 1.368

Review 9.  Host Cellular Receptors for the Peste des Petits Ruminant Virus.

Authors:  Meera Prajapati; Niyokwishimira Alfred; Yongxi Dou; Xiangping Yin; Raju Prajapati; Yanmin Li; Zhidong Zhang
Journal:  Viruses       Date:  2019-08-08       Impact factor: 5.048

10.  Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain.

Authors:  Cyrille Mathieu; Francesca T Bovier; Marion Ferren; Nicole A P Lieberman; Camilla Predella; Alexandre Lalande; Vikas Peddu; Michelle J Lin; Amin Addetia; Achchhe Patel; Victor Outlaw; Barbara Corneo; N Valerio Dorrello; Thomas Briese; Diana Hardie; Branka Horvat; Anne Moscona; Alexander L Greninger; Matteo Porotto
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.